(NYSE: ENOV) Enovis's forecast annual revenue growth rate of 4.4% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 6.97%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.88%.
Enovis's revenue in 2026 is $2,296,603,000.On average, 15 Wall Street analysts forecast ENOV's revenue for 2026 to be $137,599,412,684, with the lowest ENOV revenue forecast at $131,601,785,308, and the highest ENOV revenue forecast at $142,328,311,192. On average, 15 Wall Street analysts forecast ENOV's revenue for 2027 to be $144,289,073,988, with the lowest ENOV revenue forecast at $137,368,734,708, and the highest ENOV revenue forecast at $149,825,345,412.
In 2028, ENOV is forecast to generate $151,209,413,268 in revenue, with the lowest revenue forecast at $143,481,701,072 and the highest revenue forecast at $156,745,684,692.